Literature DB >> 6739682

Elevated daytime urinary excretion of testosterone glucuronide in men with the type A behavior pattern.

B Zumoff, R S Rosenfeld, M Friedman, S O Byers, R H Rosenman, L Hellman.   

Abstract

Urinary excretion of testosterone glucuronide was compared in 13 men with typical Type A behavior pattern (as determined by structured interviews) and 10 age-matched men with typical Type B behavior pattern. Twenty-four hour urine collections were divided into three periods: 9AM - 6PM , 6PM to bedtime, and bedtime to 9AM . Type A men showed a significantly higher excretion than Type B men in the daytime ( 9AM - 6PM ); the geometric mean value was 24 micrograms in Type A and 15 micrograms in Type B (P less than 0.05). There were no significant differences between Type A and Type B men for the other two time periods. Indicating an elevated daytime testosterone secretion in Type A men, this finding is consistent with a recent report that exposure to laboratory tests of reaction time causes an increase in plasma testosterone levels in Type A but not Type B men. Since a role for testosterone in the genesis of coronary heart disease (CHD) is suggested by the much higher incidence of CHD in men and the acceleration of murine atherogenesis by testosterone, the findings of this and the previous report may represent a mechanism for the elevated incidence of CHD in Type A men.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6739682     DOI: 10.1097/00006842-198405000-00004

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  6 in total

1.  The potential role of testosterone in central serous chorioretinopathy.

Authors:  M C Grieshaber; J-J Staub; J Flammer
Journal:  Br J Ophthalmol       Date:  2007-01       Impact factor: 4.638

2.  Type A behavior and central serous chorioretinopathy.

Authors:  L A Yannuzzi
Journal:  Trans Am Ophthalmol Soc       Date:  1986

3.  The relationship between the central serous chorioretinopathy, choroidal thickness, and serum hormone levels.

Authors:  Emine Çiloğlu; Fikret Unal; Nese Cetin Dogan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-04-18       Impact factor: 3.117

4.  Serum dehydroepiandrosterone sulphate, total antioxidant capacity, and total oxidant status in central serous chorioretinopathy.

Authors:  Fatih Mehmet Türkcü; Harun Yüksel; Hatice Yüksel; Alparslan Sahin; Yasin Cinar; Abdullah Kürşat Cingü; Muhammed Sahin; Ihsan Caça
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-06-08       Impact factor: 3.117

5.  Serum cortisol and testosterone levels in chronic central serous chorioretinopathy.

Authors:  Hasan Ali Tufan; Baran Gencer; Arzu Taskiran Comez
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-06-21       Impact factor: 3.117

6.  Serum cortisol and testosterone levels in idiopathic central serous chorioretinopathy.

Authors:  Shaik M Zakir; M Shukla; Zaka-Ur-Rab Simi; J Ahmad; Mahmood Sajid
Journal:  Indian J Ophthalmol       Date:  2009 Nov-Dec       Impact factor: 1.848

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.